You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ataxia telangiectasia mutated and Rad3-related (ATR) protein

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Pittsburgh (M1774, Cemiplimab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Cancer Center
May 22, 2023

Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

Advanced Solid Tumor, Recurrent Endometrial Cancer, Metastatic Cancer Trial (ART0380)

Not yet recruiting
  • Advanced Solid Tumor
  • +2 more
  • (no location specified)
Apr 5, 2023

Advanced Cancer, Metastatic Cancer, Ovarian Cancer Trial in United Kingdom, United States (ART0380, Gemcitabine, Irinotecan)

Recruiting
  • Advanced Cancer
  • +4 more
  • Denver, Colorado
  • +10 more
Jul 6, 2022

Advanced Solid Tumors Trial in Worldwide (Elimusertib (BAY1895344), Pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • Palo Alto, California
  • +15 more
Jan 6, 2023

Other Cancer Trial in Budapest ([14C]M6620, M6620, Topotecan)

Recruiting
  • Other Cancer
  • Budapest, Hungary
  • +1 more
Jun 22, 2022

Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Locally Advanced Merkel Cell

Not yet recruiting
  • Clinical Stage III Merkel Cell Carcinoma AJCC v8
  • +5 more
  • (no location specified)
Jul 13, 2023

Advanced Solid Tumor, Breast Cancer Trial (Niraparib, M4344)

Withdrawn
  • Advanced Solid Tumor
  • Breast Cancer
  • (no location specified)
Jun 24, 2021

Metastatic Triple Negative Breast Cancer Trial in Worldwide (Olaparib Continuous (28-Day cycle) 300 mg BD., Ceralasertib 160 mg

Active, not recruiting
Has Results
  • Metastatic Triple Negative Breast Cancer
  • Olaparib Continuous (28-Day cycle) 300 mg BD.
  • +2 more
  • Birmingham, Alabama
  • +140 more
Nov 17, 2022

Metastasis, Locally Advanced Solid Tumor, Recurrent Cancer Trial in Stanford, New York (XRD-0394, Palliative radiotherapy)

Recruiting
  • Metastasis
  • +2 more
  • Stanford, California
  • +1 more
Sep 27, 2021

Ataxia Telangiectasia Trial in Frankfurt (Lumbar puncture)

Completed
  • Ataxia Telangiectasia
  • Lumbar puncture
  • Frankfurt, Hessen, Germany
    Johann Wolfgang Goethe University Hospitals
Aug 30, 2021

Refractory Cancer Trial in Seoul (AZD6738, Paclitaxel)

Completed
  • Refractory Cancer
  • Seoul, Korea, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Pilot Study of Pancreatic Cancer Screening

Recruiting
  • Pancreatic Carcinoma
  • Biospecimen Collection
  • +4 more
  • San Francisco, California
    University of California San Francisco
Apr 13, 2022

Ataxia Telangiectasia in Children, Ataxia Telangiectasia Trial in Plymouth (Whole-body exercise and respiratory exercise)

Recruiting
  • Ataxia Telangiectasia in Children
  • Ataxia Telangiectasia
  • Whole-body exercise and respiratory exercise
  • Plymouth, United Kingdom
    University of Plymouth
Jan 19, 2023

Eye Movement Activity in an Ataxia Telangiectasia

Completed
  • Ataxia Telangiectasia
  • Dysmetria
    • Chéjov, Russian Federation
      Clinical Rehabilitation Research Center "Russkoe pole"
    Jul 20, 2022

    Ataxia Telangiectasia Trial in Lørenskog, Oslo (Nicotinamide ribonucleoside)

    Active, not recruiting
    • Ataxia Telangiectasia
    • Nicotinamide ribonucleoside
    • Lørenskog, Norway
    • +1 more
    Aug 16, 2022

    Ataxia Telangiectasia, ATM Gene Mutation Trial in Nijmegen (Vitamin B3)

    Completed
    • Ataxia Telangiectasia
    • ATM Gene Mutation
    • Vitamin B3
    • Nijmegen, Netherlands
      Radboudumc
    Jul 21, 2022

    Chronic Lymphocytic Leukemia Trial in Poland, United Kingdom (Ceralasertib, Acalabrutinib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Kraków, Poland
    • +10 more
    Dec 2, 2022

    Ovarian Cancer Recurrent Trial in Birmingham (M4344+Niraparib)

    Not yet recruiting
    • Ovarian Cancer Recurrent
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jan 5, 2023

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Biospecimen

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • +2 more
    • Biopsy
    • +6 more
    • (no location specified)
    Jan 14, 2023

    HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)

    Recruiting
    • HRD Cancer
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Ataxia Telangiectasia Louis-Bar, Ataxia Telangiectasia in Children, Ataxia Telangiectasia Trial in Houston (MBM-01)

    Not yet recruiting
    • Ataxia Telangiectasia Louis-Bar
    • +2 more
    • Houston, Texas
      University of Texas Health Science Center at Houston
    May 13, 2021

    Advanced Stage Solid Tumors Trial in Sutton (M6620, Carboplatin, Paclitaxel)

    Active, not recruiting
    • Advanced Stage Solid Tumors
    • Sutton, United Kingdom
      Royal Marsden NHS Foundation Trust
    Feb 9, 2022

    Pmm2-CDG, CDG1A Trial in Rochester, Philadelphia, Seattle (Placebo, Acetazolamide)

    Active, not recruiting
    • Pmm2-CDG
    • CDG1A
    • Rochester, Minnesota
    • +2 more
    Jan 12, 2023